Menu

• Ask a Health Expert about HYPOPERFUSION
• Post Your Side Effect related to HYPOPERFUSION
• HYPOPERFUSION and FDA Warnings
• HYPOPERFUSION in Patients Wiki
• Report HYPOPERFUSION in Drug Side Effect Survey

HYPOPERFUSION side effect

What is HYPOPERFUSION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Morphine Side Effects Report #5647853-7
Consumer or non-health professional from reported MORPHINE problem on Feb 28, 2008. Female patient was diagnosed with neonatal respiratory distress syndrome and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, . MORPHINE dosage: unknown. During the same period patient was treated with CUROSURF, MIDAZOLAM. Patient recovered.

Risperidone Side Effects Report #5622816-6
RISPERIDONE problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Male patient, 67 years of age, was treated with RISPERIDONE. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, hypotension, oliguria, overdose, pleural effusion, pulmonary oedema, sinus bradycardia, . RISPERIDONE dosage: unknown. During the same period patient was treated with ATENOLOL. Patient was hospitalized. Patient recovered.

Atenolol Side Effects Report #5588519-1
Health Professional from UNITED STATES reported ATENOLOL problem on Jan 07, 2008. Male patient, 67 years of age, was treated with ATENOLOL. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, hypotension, oliguria, overdose, pleural effusion, pulmonary oedema, sinus bradycardia, . ATENOLOL dosage: unknown. During the same period patient was treated with RISPERIDONE. Patient recovered.

Magnevist Side Effects Report #5597037-6
MAGNEVIST problem was reported by a Physician from UNITED STATES on Jan 11, 2008. Female patient, 72 years of age, was diagnosed with angiogram and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, myocardial infarction, renal failure, . MAGNEVIST dosage: UNIT DOSE: 35 ML. During the same period patient was treated with PREVACID, ALPRAZOLAM, PRAVASTATIN, ADVAIR DISKUS, HUMULIN R. Patient was hospitalized. Patient recovered.


Propofolectable Side Effects Report #5782986-6
Physician from CHILE reported PROPOFOLECTABLE EMULSION problem on June 10, 2008. Female patient, 43 years of age, was treated with PROPOFOLECTABLE EMULSION. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, lactic acidosis, . PROPOFOLECTABLE EMULSION dosage: 58 MCG/KG/MIN, 3.5 MG/KG, TWICE, INFUSION; 3.5 MG/KG, INFUSION. During the same period patient was treated with PROPOFOLECTABLE EMULSION, PROPOFOLECTABLE EMULSION, VALPROIC ACID, REMIFENTANYL, LORAZEPAM, MIDAZOLAM, FLUIDS. Patient recovered.

Evicel Side Effects Report #5663765-7
EVICEL problem was reported by a Physician from UNITED STATES on Feb 24, 2008. Female patient was diagnosed with carotid endarterectomy and was treated with EVICEL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, hypoperfusion, procedural complication, . EVICEL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Myozyme Side Effects Report #5579302-1
Physician from UNITED STATES reported MYOZYME problem on Dec 14, 2007. Female patient, weighting 7.72 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hypoperfusion, . MYOZYME dosage: 20 MG/KG, ONCE, INTRAVENOUS. Patient was hospitalized. Patient died on 12/16/2007.

Metformin Side Effects Report #5507246-X
METFORMIN problem was reported by a Pharmacist from UNITED STATES on Nov 05, 2007. Male patient, 74 years of age, weighting 165.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal ischaemia, hypoperfusion, metabolic acidosis, renal impairment, . METFORMIN dosage: 500MG PO QDAY. During the same period patient was treated with ASPIRIN, LANTUS, ALTACE. Patient was hospitalized. Patient recovered.

Ciprofloxacin Side Effects Report #5256056-X
Health Professional from UNITED KINGDOM reported CIPROFLOXACIN problem on Feb 15, 2007. Female patient, 43 years of age, was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: hypoperfusion, hypovolaemia, nephritis interstitial, renal failure acute, sepsis, . CIPROFLOXACIN dosage: 500 MG, BID, ORAL. During the same period patient was treated with ACYCLOVIR, ADIZEM, ALLOPURINOL, CANDESARTAN, CASPOFUNGIN. Patient was hospitalized. Patient recovered.


Myozyme Side Effects Report #5587783-2
MYOZYME problem was reported by a Physician from UNITED STATES on Dec 27, 2007. Female patient, weighting 7.72 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, hypoperfusion, pyrexia, . MYOZYME dosage: 20 MG/KG, ONCE, INTRAVENOUS. During the same period patient was treated with MILRINONE, FENTANYL, DOPAMINE, ESMOLOL, EPINEPHRINE, PANCURONIUM, FUROSEMIDE, VANCOMYCIN. Patient was hospitalized. Patient died on 12/16/2007.

Gleevec Side Effects Report #5450836-3
Physician from UNITED STATES reported GLEEVEC problem on Sept 07, 2007. Female patient, 62 years of age, was diagnosed with chronic myeloid leukaemia, hypertension, pain and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, hypoperfusion, optic ischaemic neuropathy, . GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with ATENOLOL, DYAZIDE, DARVOCET. Patient recovered.

Teveten Side Effects Report #5332861-6
TEVETEN problem was reported by a Pharmacist from UNITED KINGDOM on Apr 25, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, hypoperfusion, pulmonary hypoplasia, stillbirth, . TEVETEN dosage: 600 MG DAILY. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died on 10/22/2006.

Metformin Side Effects Report #5341462-5
Consumer or non-health professional from SPAIN reported METFORMIN problem on May 14, 2007. Male patient, 73 years of age, was diagnosed with blood glucose increased and was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: haemodialysis, hypercalcaemia, hypoperfusion, lactic acidosis, loss of consciousness, oxygen saturation decreased, renal impairment, shock, . METFORMIN dosage: 850 MG, Q8H. During the same period patient was treated with CLOPIDOGREL, SIMVASTATIN, ENOXAPARIN, ENALAPRIL, CLOMETHIAZOLE, HALOPERIDOL, INSULIN. Patient recovered.

Dianben Side Effects Report #5343426-4
DIANBEN problem was reported by a Consumer or non-health professional from SPAIN on May 18, 2007. Male patient, 73 years of age, was diagnosed with diabetes mellitus and was treated with DIANBEN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, hypercalcaemia, hypoperfusion, lactic acidosis, loss of consciousness, oxygen saturation decreased, pneumonia aspiration, renal impairment, shock, . DIANBEN dosage: 2550 MG (850 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ENALAPRIL MALEATE, CLOPIDOGREL, SIMVASTATIN, CLOMETHIAZOLE, HALOPERIDOL, ENOXAPRIN, INSULIN. Patient was hospitalized. Patient recovered.


Certican Side Effects Report #5305306-X
Physician from SLOVAKIA (Slovak Republic) reported CERTICAN problem on Apr 13, 2007. Female patient, 58 years of age, was diagnosed with renal transplant and was treated with CERTICAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, complications of transplant surgery, hypoperfusion, kidney transplant rejection, nephrectomy, renal necrosis, treatment noncompliance, . CERTICAN dosage: 1.5 MG, BID. During the same period patient was treated with NEORAL. Patient recovered.

Teveten Side Effects Report #5288299-3
TEVETEN problem was reported by a Pharmacist from UNITED KINGDOM on Mar 15, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, hypoperfusion, . TEVETEN dosage: 600 MG DAILY PO; A FEW WEEKS. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died.

Teveten Side Effects Report #5288303-2
Pharmacist from UNITED KINGDOM reported TEVETEN problem on Mar 15, 2007. Female patient was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, hypoperfusion, . TEVETEN dosage: 600 MG DAILY PO; A FEW WEEKS. During the same period patient was treated with METFORMIN, BENDROFLUAZIDE. Patient died.